Zeria Pharmceutical Co., Ltd. Stock: price and insider trades · Japan
ゼリア新薬工業株式会社
No insider purchase over the last 90 days. The latest, by Ibe, was filed 16 May 2024.
Zeria Pharmceutical Co., Ltd.: what insiders have been doing
Zeria Pharmceutical Co., Ltd., founded in 1955, is a Health Care company based in Chūō, Japan. Its directors and officers file their transactions with EDINET (Japan FSA). Nothing new has been filed by managers of Zeria Pharmceutical Co., Ltd. in twelve months, the latest record being from 29 July 2024.
Over the whole record (from 2021), the tally stands at 38 purchases and 21 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Since the insiders bought
- +7.2%Entry JP¥2,001 · Close at T+365 JP¥2,146
- +6.9%Entry JP¥2,098 · Close at T+365 JP¥2,242
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- ShareXTKSEDINET:S100U3FU
- 100.0% of flowShareXTKSEDINET:S100TBRM
- 588,500 shares@ JP¥2,039.00100.0% of flowShareXOFFEDINET:S100TBRM:T1Canonical exit: 11 Aug 2024 (T+90)
- 100.0% of flowShareXTKSEDINET:S100T8HR
- 100 shares@ JP¥2,146.99480.3% of flowShareXOFFEDINET:S100T8HR:T42Canonical exit: 2 Jun 2024 (T+90)
- 200 sharesShareXTKSEDINET:S100T8HR:T2
- 100 sharesShareXTKSEDINET:S100T8HR:T3Canonical exit: 2 May 2024 (T+90)
- 2,600 shares@ JP¥2,208.89979.5% of flowShareXOFFEDINET:S100T8HR:T1Canonical exit: 2 May 2024 (T+90)
- 100 sharesShareXTKSEDINET:S100T8HR:T7Canonical exit: 5 May 2024 (T+90)
- 100 shares@ JP¥2,221.20580.4% of flowShareXOFFEDINET:S100T8HR:T4
- 100 sharesShareXTKSEDINET:S100T8HR:T9Canonical exit: 6 May 2024 (T+90)
- 500 shares@ JP¥2,210.99921.8% of flowShareXOFFEDINET:S100T8HR:T10
- 200 sharesShareXTKSEDINET:S100T8HR:T13Canonical exit: 8 May 2024 (T+90)
- 100 sharesShareXTKSEDINET:S100T8HR:T16
- 300 sharesShareXTKSEDINET:S100T8HR:T17Canonical exit: 13 May 2024 (T+90)
- 800 sharesShareXTKSEDINET:S100T8HR:T18Canonical exit: 15 May 2024 (T+90)
- 500 sharesShareXTKSEDINET:S100T8HR:T20Canonical exit: 16 May 2024 (T+90)
- 200 sharesShareXTKSEDINET:S100T8HR:T22Canonical exit: 19 May 2024 (T+90)
- 200 sharesShareXTKSEDINET:S100T8HR:T24
- 300 sharesShareXTKSEDINET:S100T8HR:T26Canonical exit: 21 May 2024 (T+90)
- 1,200 sharesShareXTKSEDINET:S100T8HR:T29Canonical exit: 22 May 2024 (T+90)
- 100 shares@ JP¥2,148.99280.3% of flowShareXOFFEDINET:S100T8HR:T27Canonical exit: 22 May 2024 (T+90)
- 200 shares@ JP¥2,149.00150.7% of flowShareXOFFEDINET:S100T8HR:T31Canonical exit: 26 May 2024 (T+90)
- 1,300 sharesShareXTKSEDINET:S100T8HR:T35Canonical exit: 28 May 2024 (T+90)
- 400 sharesShareXTKSEDINET:S100T8HR:T39Canonical exit: 30 May 2024 (T+90)
25 of 64 declarations
About Zeria Pharmceutical Co., Ltd.
Zeria Pharmaceutical Co., Ltd. is a Japanese company specializing in the health and pharmaceutical sector. It focuses on the research, development, and marketing of innovative medicines.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
